Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Current Opinion in Molecular Therapeutics
|
June 5, 2002
Technology evaluation: adalimumab, Abbott laboratories
Hanns M Lorenz
Annals of the New York Academy of Sciences
|
March 23, 2004
Accumulation of histones in cell lysates precedes expression of apoptosis-related phagocytosis signals in human lymphoblasts
Christoph Gabler, Norbert Blank, Silke Winkler, et al.
Journal of the American Society of Nephrology : JASN
|
January 23, 2003
15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy
Rainer Birck, Klaus Warnatz, Hanns M Lorenz, et al.
Molecular Pharmacology
|
January 27, 2004
Bucillamine induces the synthesis of vascular endothelial growth factor dose-dependently in systemic sclerosis fibroblasts via nuclear factor-kappaB and simian virus 40 promoter factor 1 pathways
Jörg H W Distler, Claudia Hagen, Astrid Hirth, et al.
Arthritis and Rheumatism
|
March 8, 2005
Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis
Jörg H W Distler, Astrid Jüngel, Otylia Kowal-Bielecka, et al.
Clinical and Experimental Rheumatology
|
February 24, 2022
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies
Lorenzo Cavagna, Federica Meloni, Alain Meyer, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Current Opinion in Molecular Therapeutics
|
June 5, 2002
Technology evaluation: adalimumab, Abbott laboratories
Hanns M Lorenz
Annals of the New York Academy of Sciences
|
March 23, 2004
Accumulation of histones in cell lysates precedes expression of apoptosis-related phagocytosis signals in human lymphoblasts
Christoph Gabler, Norbert Blank, Silke Winkler, et al.
Journal of the American Society of Nephrology : JASN
|
January 23, 2003
15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy
Rainer Birck, Klaus Warnatz, Hanns M Lorenz, et al.
Molecular Pharmacology
|
January 27, 2004
Bucillamine induces the synthesis of vascular endothelial growth factor dose-dependently in systemic sclerosis fibroblasts via nuclear factor-kappaB and simian virus 40 promoter factor 1 pathways
Jörg H W Distler, Claudia Hagen, Astrid Hirth, et al.
Arthritis and Rheumatism
|
March 8, 2005
Expression of interleukin-21 receptor in epidermis from patients with systemic sclerosis
Jörg H W Distler, Astrid Jüngel, Otylia Kowal-Bielecka, et al.
Clinical and Experimental Rheumatology
|
February 24, 2022
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies
Lorenzo Cavagna, Federica Meloni, Alain Meyer, et al.
Page
of 1